Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-8800
Fax+1 214-645-8238
Dr. Okuda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Neuroimmunology & Multiple Sclerosis, 2004 - 2006
Barrow Neurological Institute at St Joseph's Hospital and Medical CenterResidency, Neurology, 2001 - 2004
Creighton University School of MedicineInternship, Internal Medicine, 2000 - 2001
University of Hawaii, John A. Burns School of MedicineClass of 2000
Certifications & Licensure
AZ State Medical License 2002 - Present
CA State Medical License 2004 - 2026
TX State Medical License 2013 - 2025
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
- Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS) Start of enrollment: 2016 Mar 19
Publications & Presentations
PubMed
- Dynamic Expansion and Contraction of Multiple Sclerosis T2-Weighted Hyperintense Lesions Are Present below the Threshold of Visual Perception.Darin T Okuda, Tatum M Moog, Morgan McCreary, Kevin Shan, Kasia Zubkow
AJNR. American Journal of Neuroradiology. 2025-02-03 - Analysis of healthcare utilization before the diagnosis of radiologically isolated syndrome.Christine Lebrun-Frenay, Sandrine Kerbrat, Darin T Okuda, Cassandre Landes-Chateau, Orhun H Kantarci
Multiple Sclerosis. 2025-02-01 - Faster and better than a physician?: Assessing diagnostic proficiency of ChatGPT in misdiagnosed individuals with neuromyelitis optica spectrum disorder.Kevin Shan, Mahi A Patel, Morgan McCreary, Tom G Punnen, Francisco Villalobos
Journal of the Neurological Sciences. 2025-01-15
Press Mentions
How a Pioneering Diabetes Drug Offers Hope for Preventing Autoimmune DisordersFebruary 15th, 2023- Biomarkers, Diet, Progressive MS, and Epstein-Barr Virus Among Research News Shared at ECTRIMSNovember 4th, 2022
- Can First MS Symptoms Be Delayed?October 31st, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
